SCOPUS 정보 검색 플랫폼

Pharmacotherapy

Volumn 27, Issue 3, 2007, Pages 455-458

Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course

(2) Lewis, Melissa a Amsden, Jarrett R b,c

a Walgreens (United States)

b BUTLER UNIVERSITY (United States)

c Podiatry (United States)

Author keywords

Interferon; Interferon 2b; Meningoencephalitis; West Nile virus; WNV

Indexed keywords

ACICLOVIR; ALPHA2B INTERFERON; CEFTRIAXONE; DOXYCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; RIBAVIRIN; VANCOMYCIN;

AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; HUMAN; MALE; MENINGOENCEPHALITIS; SINGLE DRUG DOSE; TREATMENT OUTCOME; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS;

AGED, 80 AND OVER; HUMANS; INTERFERON ALFA-2B; INTERFERONS; MALE; MENINGOENCEPHALITIS; TIME FACTORS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 33847257454 PISSN: 02770008 EISSN: None Source Type: Journal
DOI: 10.1592/phco.27.3.455 Document Type: Article

Times cited : (32)

References (8)

1
- 33847250887
- Emerging viral infections. West Nile Virus
- Schumock G, Brundage D, Chapman M, et al, eds, 5th ed. Kansas City, MO: American College of Clinical Pharmacy
- Jackson AB. Emerging viral infections. West Nile Virus. In: Schumock G, Brundage D, Chapman M, et al, eds. Pharmacotherapy self-assessment program, 5th ed. Kansas City, MO: American College of Clinical Pharmacy. 2005:61-5.
- (2005) Pharmacotherapy self-assessment program , pp. 61-65
- Jackson, A.B.¹

2
- 0037454351
- Clinical review: West Nile encephalitis
- Solomon T, Ooi MH, Beasley DWC, Mallewa M. Clinical review: West Nile encephalitis. BMJ 2003;326:865-9.
- (2003) BMJ , vol.326 , pp. 865-869
- Solomon, T.¹ Ooi, M.H.² Beasley, D.W.C.³ Mallewa, M.⁴

3
- 1842539502
- West Nile virus: Pathogenesis and therapeutic options
- Gea-Banacloche J, Johnson RT, Bagic A, Butman JA, Murray PR, Agrawal AG. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 2004;140:545-54.
- (2004) Ann Intern Med , vol.140 , pp. 545-554
- Gea-Banacloche, J.¹ Johnson, R.T.² Bagic, A.³ Butman, J.A.⁴ Murray, P.R.⁵ Agrawal, A.G.⁶

4
- 0036151539
- Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro
- Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002;8:107-8.
- (2002) Emerg Infect Dis , vol.8 , pp. 107-108
- Anderson, J.F.¹ Rahal, J.J.²

5
- 4444287642
- Effect of interferon alpha-2b therapy on St. Louis viral meningoencephalitis: Clinical and laboratory results of a pilot study
- Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon alpha-2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis 2004;190:1084-7.
- (2004) J Infect Dis , vol.190 , pp. 1084-1087
- Rahal, J.J.¹ Anderson, J.² Rosenberg, C.³ Reagan, T.⁴ Thompson, L.L.⁵

6
- 15044352317
- Use of interferon-alpha in patients with West Nile encephalitis: Report of 2 cases
- Kalil AC, Devetten MP, Singh S, et al. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis 2005;40:764-6.
- (2005) Clin Infect Dis , vol.40 , pp. 764-766
- Kalil, A.C.¹ Devetten, M.P.² Singh, S.³

7
- 33847283320
- West Nile virus. Available from, Accessed May 8, 2006
- Centers for Disease Control and Prevention. West Nile virus. Available from http://www.cdc.gov/ncidod/dvbid/westnile/index. htm. Accessed May 8, 2006.

8
- 0034767753
- Antiviral actions of interferons
- Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-800.
- (2001) Clin Microbiol Rev , vol.14 , pp. 778-800
- Samuel, C.E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.